Treatment of Female Sexual Dysfunction Due to Dyspareunia with Solid-State Vaginal Laser and Recombinant Platelet-Derived Epidermal Growth Factors: A Viable Possibility?
Objective: To examine the efficacy and safety of non-pharmacological and non-ablative options (or a combination of these) for postmenopausal dyspareunia. Mechanism: Narrative review on non-pharmacological and non-ablative options (or a combination of these) for postmenopausal dyspareunia. Findings i...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IMR Press
2023-02-01
|
| Series: | Clinical and Experimental Obstetrics & Gynecology |
| Subjects: | |
| Online Access: | https://www.imrpress.com/journal/CEOG/50/2/10.31083/j.ceog5002040 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850165763117154304 |
|---|---|
| author | Nicolas Mendoza Francisco Quereda |
| author_facet | Nicolas Mendoza Francisco Quereda |
| author_sort | Nicolas Mendoza |
| collection | DOAJ |
| description | Objective: To examine the efficacy and safety of non-pharmacological and non-ablative options (or a combination of these) for postmenopausal dyspareunia. Mechanism: Narrative review on non-pharmacological and non-ablative options (or a combination of these) for postmenopausal dyspareunia. Findings in Brief: Dyspareunia is the most bothersome symptom of the genitourinary syndrome of menopause, often complicated by decreased sexual interest and arousal. Solid-state vaginal laser (SSVL) and recombinant platelet-derived epidermal growth factors (RGFs) are new alternatives are new alternatives that improve female sexual dysfunction resulting from dyspareunia. Conclusions: SSVL is a new alternative the treatment of postmenopausal dyspareunia either alone or in combination with other alternatives with efficacy and safety similar to the classical options. |
| format | Article |
| id | doaj-art-edbe9e1ee4d648b3ae3591e2a015c074 |
| institution | OA Journals |
| issn | 0390-6663 |
| language | English |
| publishDate | 2023-02-01 |
| publisher | IMR Press |
| record_format | Article |
| series | Clinical and Experimental Obstetrics & Gynecology |
| spelling | doaj-art-edbe9e1ee4d648b3ae3591e2a015c0742025-08-20T02:21:39ZengIMR PressClinical and Experimental Obstetrics & Gynecology0390-66632023-02-015024010.31083/j.ceog5002040S0390-6663(22)01969-8Treatment of Female Sexual Dysfunction Due to Dyspareunia with Solid-State Vaginal Laser and Recombinant Platelet-Derived Epidermal Growth Factors: A Viable Possibility?Nicolas Mendoza0Francisco Quereda1Department of Obstetrics and Gynecology, Faculty of Medicine, Granada University, 18004 Granada, SpainDepartment of Obstetrics and Gynecology, The University of Alicante, 03690 Alicante, SpainObjective: To examine the efficacy and safety of non-pharmacological and non-ablative options (or a combination of these) for postmenopausal dyspareunia. Mechanism: Narrative review on non-pharmacological and non-ablative options (or a combination of these) for postmenopausal dyspareunia. Findings in Brief: Dyspareunia is the most bothersome symptom of the genitourinary syndrome of menopause, often complicated by decreased sexual interest and arousal. Solid-state vaginal laser (SSVL) and recombinant platelet-derived epidermal growth factors (RGFs) are new alternatives are new alternatives that improve female sexual dysfunction resulting from dyspareunia. Conclusions: SSVL is a new alternative the treatment of postmenopausal dyspareunia either alone or in combination with other alternatives with efficacy and safety similar to the classical options.https://www.imrpress.com/journal/CEOG/50/2/10.31083/j.ceog5002040female sexual dysfunctiongenitourinary syndrome of menopausedyspareuniasolid-state vaginal laserepidermal growth factors |
| spellingShingle | Nicolas Mendoza Francisco Quereda Treatment of Female Sexual Dysfunction Due to Dyspareunia with Solid-State Vaginal Laser and Recombinant Platelet-Derived Epidermal Growth Factors: A Viable Possibility? Clinical and Experimental Obstetrics & Gynecology female sexual dysfunction genitourinary syndrome of menopause dyspareunia solid-state vaginal laser epidermal growth factors |
| title | Treatment of Female Sexual Dysfunction Due to Dyspareunia with Solid-State Vaginal Laser and Recombinant Platelet-Derived Epidermal Growth Factors: A Viable Possibility? |
| title_full | Treatment of Female Sexual Dysfunction Due to Dyspareunia with Solid-State Vaginal Laser and Recombinant Platelet-Derived Epidermal Growth Factors: A Viable Possibility? |
| title_fullStr | Treatment of Female Sexual Dysfunction Due to Dyspareunia with Solid-State Vaginal Laser and Recombinant Platelet-Derived Epidermal Growth Factors: A Viable Possibility? |
| title_full_unstemmed | Treatment of Female Sexual Dysfunction Due to Dyspareunia with Solid-State Vaginal Laser and Recombinant Platelet-Derived Epidermal Growth Factors: A Viable Possibility? |
| title_short | Treatment of Female Sexual Dysfunction Due to Dyspareunia with Solid-State Vaginal Laser and Recombinant Platelet-Derived Epidermal Growth Factors: A Viable Possibility? |
| title_sort | treatment of female sexual dysfunction due to dyspareunia with solid state vaginal laser and recombinant platelet derived epidermal growth factors a viable possibility |
| topic | female sexual dysfunction genitourinary syndrome of menopause dyspareunia solid-state vaginal laser epidermal growth factors |
| url | https://www.imrpress.com/journal/CEOG/50/2/10.31083/j.ceog5002040 |
| work_keys_str_mv | AT nicolasmendoza treatmentoffemalesexualdysfunctionduetodyspareuniawithsolidstatevaginallaserandrecombinantplateletderivedepidermalgrowthfactorsaviablepossibility AT franciscoquereda treatmentoffemalesexualdysfunctionduetodyspareuniawithsolidstatevaginallaserandrecombinantplateletderivedepidermalgrowthfactorsaviablepossibility |